Genodermatoses with malignant potential
作者： Ryan Ladd , Matthew Davis , Jonathan A. Dyer
DOI: 10.1016/J.CLINDERMATOL.2020.03.007
关键词: Multiple endocrine neoplasia 、 Identification (biology) 、 Genetic therapy 、 Birt–Hogg–Dubé syndrome 、 Intensive care medicine 、 Genetic testing 、 Etiology 、 Medicine 、 Cancer 、 Hereditary Cancer Syndromes
摘要: The hereditary nature of some forms cancer was recognized long ago. Over time, recognition associated findings led to the delineation numerous syndromes. Many these syndromes also have cutaneous manifestations, which can lead their early identification. Recognition allows vigilant surveillance and preemptive treatment, dramatically impact risks morbidity mortality for affected patients. rise rapid accurate genetic testing now identification asymptomatic at risk family members so that monitoring be initiated as possible. dermatologist plays a critical role in and, many cases, treatment. This review summarizes known with findings, etiology, identification, evaluation, management. Importantly, this is an ever evolving topic new will continue recognized. must always alert ensure they are detected.
cidjournal.com参考文章(128)
Brian P. Brooks, Amy H. Thompson, Rachel J. Bishop, Janine A. Clayton, Chi-Chao Chan, Ekaterini T. Tsilou, Wadih M. Zein, Deborah Tamura, Sikandar G. Khan, Takahiro Ueda, Jennifer Boyle, Kyu-Seon Oh, Kyoko Imoto, Hiroki Inui, Shin-Ichi Moriwaki, Steffen Emmert, Nicholas T. Iliff, Porcia Bradford, John J. DiGiovanna, Kenneth H. Kraemer, Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage. Ophthalmology. ,vol. 120, pp. 1324- 1336 ,(2013) , 10.1016/J.OPHTHA.2012.12.044
Eldon J. Gardner, Ralph C. Richards, Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. American Journal of Human Genetics. ,vol. 5, pp. 139- 147 ,(1953)
H. J. R. Bussey, Familial polyposis coli : family studies, histopathology, differential diagnosis, and results of treatment Johns Hopkins University Press. ,(1975)
Peter A. Farndon, The Gorlin (nevoid basal cell carcinoma) syndrome Genetic Predisposition to Cancer. pp. 164- 184 ,(1996) , 10.1007/978-1-4899-4501-3_11
John M Carethers, Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer World Journal of Gastroenterology. ,vol. 21, pp. 9253- 9261 ,(2015) , 10.3748/WJG.V21.I31.9253
Jeffrey A. Norton, Geoffrey Krampitz, Robert T. Jensen, Multiple Endocrine Neoplasia Surgical Oncology Clinics of North America. ,vol. 24, pp. 795- 832 ,(2015) , 10.1016/J.SOC.2015.06.008
Ramune Reliene, Robert H. Schiestl, Experimental antioxidant therapy in ataxia telangiectasia Clinical Medicine: Oncology. ,vol. 2, pp. 431- 436 ,(2008) , 10.4137/CMO.S535
Stéphane Chavanas, Christine Bodemer, Ariane Rochat, Dominique Hamel-Teillac, Mohsin Ali, Alan D Irvine, Jean-Louis Bonafé, John Wilkinson, Alain Taïeb, Yann Barrandon, John I Harper, Yves De Prost, Alain Hovnanian, None, Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nature Genetics. ,vol. 25, pp. 141- 142 ,(2000) , 10.1038/75977
Barbara A. Gilchrest, David J. Leffell, Stephen I. Katz, Thomas B. Fitzpatrick, Lowell A. Goldsmith, Amy S. Paller, Klaus Wolff, Fitzpatrick's dermatology in general medicine. ,(1999)
K. Rai, R. Pilarski, C.M. Cebulla, M.H. Abdel-Rahman, Comprehensive review ofBAP1tumor predisposition syndrome with report of two new cases Clinical Genetics. ,vol. 89, pp. 285- 294 ,(2016) , 10.1111/CGE.12630